Exhibit 99.1 SS Innovations Reports Third Quarter 2025 Financial Results Quarterly Revenue Increased 192.5% Year over Year to $12.8 Million Driven by Higher SSi Mantra 3 Unit Sales Fort Lauderdale, FL – October 28, 2025 – SS Innovations International, Inc. (the "Company" or "SS Innovations") (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three and ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-42615 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) (Address of Principal Executive Offices) Registrant's telephone number, ...

Quarterly Revenue Increased 192.5% Year over Year to $12.8 Million Driven by Higher SSi Mantra 3 Unit SalesFORT LAUDERDALE, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three and nine months ended September 30, 2025. The Company also fi ...

公司近期活动 - 公司管理层计划参加2025年11月11日于佛罗里达州棕榈滩花园举行的UBS全球医疗会议，并将在全天安排一对一及小组会议 [2][3] - 公司管理层计划参加2025年11月12日于纽约举行的Stifel 2025医疗会议，小组演示定于东部时间下午4:40进行，并将在全天安排一对一及小组会议 [2][4] - Stifel会议的小组演示将在公司网站提供直播与回放 [4] 公司业务与产品 - 公司致力于开发创新手术机器人技术，旨在使机器人手术在全球范围内更经济实惠和易于获取 [2][5] - 公司产品组合包括专有的SSi Mantra手术机器人系统及全面的SSi Mudra手术器械，支持包括机器人心脏手术在内的多种外科手术 [5] - SSi Mantra系统具有用户友好、模块化、多机械臂的特点，配备3至5个模块化机械臂、开放式人体工学医生控制台、大型3D 4K显示器等先进技术特性 [7] 运营与临床进展 - 截至2025年9月30日，SSi Mantra系统在已获监管批准的六个国家累计安装基数为125台，其中119家医院已完成安装 [6] - 使用SSi Mantra系统已完成超过6000例外科手术，其中包括60例远程手术和310例心脏手术 [6] - SSi Mantra系统在印度已通过超过100种不同类型外科手术的临床验证，并利用超过40种不同类型的机器人内窥镜手术器械支持不同专科 [8]

FORT LAUDERDALE, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer, and Dr. Vishwa Srivastava, Chief Executive Officer – Asia Pacific, are scheduled to participate in the following upcoming investor ...

Company successfully completed a human factors validation study at Johns Hopkins Hospital Anticipates submitting a 510(k) premarket notification to the FDA in the fourth quarter of 2025 FORT LAUDERDALE, Fla., Oct. 02, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company success ...

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. SS Innovations International, Inc. is one of them. SS Innovations International, Inc. (NASDAQ:SSII) is advancing affordable surgical robotics with its flagship SSi Mantra system, offering a cost-efficient alternative to established platforms like Intuitive Surgical’s da Vinci. Approved in seven countries, including India, Indonesia, and the Philippines, the company is pursuing regulatory approval in the U.S. and Europe to ...

SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer Fort Lauderdale, FL – September 26, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Naveen Kumar Amar as the Company’s Chief Financial Officer, effe ...

公司人事任命 - SS Innovations International, Inc 任命 Naveen Kumar Amar 为首席财务官，自2025年9月24日起生效 [1] - 前任临时首席财务官 Dr Vishwa Srivastava 将继续担任公司亚太区首席执行官职务 [1] 新任首席财务官背景 - Naveen Kumar Amar 拥有超过25年的全球金融领导经验，涵盖财务会计与报告、规划与分析、预算、预测、公司财务、资金运营等领域 [2] - 其曾被福布斯印度杂志、福布斯亚洲杂志等多家出版物和组织认可为印度顶级财务高管之一 [2] - 最近曾为美国、加拿大和英国的客户提供虚拟首席财务官服务，此前曾在SpiceXpress、Munch Ado India Private Ltd等公司担任高级财务职位 [3] 公司业务与产品 - 公司致力于开发创新手术机器人技术，旨在使机器人手术在全球范围内更易负担和获取 [5] - 公司产品包括专有的SSi Mantra手术机器人系统和SSi Mudra手术器械套件，支持包括机器人心脏手术在内的多种外科手术 [5] - SSi Mantra系统是一个用户友好、模块化的多臂系统，具有3至5个模块化机械臂、3D 4K监视器等先进技术特性，并在印度经过超过100种不同类型外科手术的临床验证 [6]

公司技术突破 - 公司成功完成全球首例使用SSi Mantra手术机器人系统的儿科肾盂成形远程手术 距离达1000英里 [2] - SSi Mantra系统已累计完成超过50例远程手术 最远距离达4000英里 [5] - 系统配备3-5个模块化机械臂 支持40多种机器人内窥镜手术器械 包含3D 4K监视器和实时影像叠加功能 [7] 临床应用与市场定位 - 手术机器人系统相比传统方法具有更精确 微创 疼痛轻和恢复快的优势 [3] - 公司重点拓展儿科手术机器人市场 计划开发更小型器械以满足儿科需求 [5] - 系统已在印度经过100多种外科手术的临床验证 覆盖心脏 泌尿 妇科 肿瘤和普外科等领域 [7][9] 财务表现 - 公司当期营业收入1000万美元 较上年同期600万美元增长66.7% [1] - 毛利润240万美元 同比增长35.3% 毛利率为24% [1] - 研发投入73万美元 同比增长11.4% 行政费用101万美元 同比增长147% [1] - 净利润33万美元 同比大幅增长518% 基本每股收益0.02美元 [1] 战略发展 - 公司通过远程手术能力拓展农村和偏远地区市场 推动手术机器人技术普及 [3] - 作为总部位于印度的美国公司 计划在全球推广其技术先进 用户友好且成本效益高的手术机器人解决方案 [6]